Abnormal aldolase level
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal lactate dehydrogenase activity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of finger
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the cerebellar vermis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the metacarpal bones
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acute Cerebrovascular Accidents
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study).
|
30924762 |
2019 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Here we have screened PTEN-deficient glioblastoma for SKIP protein expression by immunohistochemistry and report that SKIP expression is increased in some cases or decreased relative to normal brain.
|
25241900 |
2015 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Both PTEN-deficient (U-251) and PTEN-containing (LN229) glioblastoma cells showed a decrease in cell migration velocity in response to SKIP downregulation.
|
30695232 |
2019 |
AICARDI-GOUTIERES SYNDROME
|
0.010 |
Biomarker
|
disease |
BEFREE |
We functionally confirmed this association in siRNA knockdown experiments of five PGC genes (p53CSV, MAP3K11, MTCH2, CPSF6, and SKIP), which either directly enhanced the invasive capacities or inhibited the proliferation of AGS cancer cells.
|
18636107 |
2008 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Since microtubule - Tau organization and dynamics is central in axonal microtubule cytoskeleton and transport, tightly related to aging processes and Alzheimer's disease, our current study provides a compelling molecular explanation to the <i>in vivo</i> activity of SKIP, placing SKIP motif as a central focus for MT-based neuroprotection in tauopathies with axonal transport implications.
|
31632241 |
2019 |
Anxiety
|
0.010 |
Biomarker
|
disease |
BEFREE |
They reported their age, gender, nationality, marital status, education and employment status, and completed two psychological questionnaires (PPS-4 and the anxiety and depression scales of the Symptom Checklist-90-Revised, SCL 90-R).
|
29434563 |
2018 |
Anxiety Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
They reported their age, gender, nationality, marital status, education and employment status, and completed two psychological questionnaires (PPS-4 and the anxiety and depression scales of the Symptom Checklist-90-Revised, SCL 90-R).
|
29434563 |
2018 |
Aplasia/Hypoplasia involving the skeletal musculature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.
|
30601470 |
2019 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.
|
30601470 |
2019 |
Avascular necrosis of the capital femoral epiphysis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bladder Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SKIP expression is correlated with clinical prognosis in patients with bladder cancer.
|
24817966 |
2014 |
Brachydactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression and prognostic role of SKIP in human breast carcinoma.
|
24150787 |
2014 |
Carcinoma of bladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SKIP expression is correlated with clinical prognosis in patients with bladder cancer.
|
24817966 |
2014 |
Cardiovascular Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Two cohorts initially recruited to study predictors of cardiovascular disease (the PPS cohort and the GOT-MONICA cohort) were followed from 1990 to 2011.
|
28600978 |
2017 |
Cataract
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Recently, pathogenic variants in INPP5K have been reported in families with congenital muscular dystrophies, intellectual disability, and cataract.
|
28940338 |
2018 |
Cataract
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|